Michael A. DesJardin - Mar 2, 2023 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
EVP, Technical Operations
Signature
/s/ Patrick McIlvenny, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
Mar 2, 2023
Transactions value $
$66,953
Form type
4
Date filed
3/6/2023, 03:48 PM
Previous filing
Jan 6, 2023
Next filing
Oct 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise $54.2K +3.63K +2.97% $14.93* 126K Mar 2, 2023 Direct
transaction HZNP Ordinary Shares Options Exercise $12.8K +743 +0.59% $17.19* 127K Mar 2, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Stock Option (Right to Buy) Options Exercise $0 -3.63K -100% $0.00* 0 Mar 2, 2023 Ordinary Shares 3.63K $14.93 Direct F1
transaction HZNP Stock Option (Right to Buy) Options Exercise $0 -743 -100% $0.00* 0 Mar 2, 2023 Ordinary Shares 743 $17.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is fully vested.